Merck Gets Bellwether Suit Slashed In Fosamax MDL
By Erin Fuchs · August 30, 2011, 6:21 PM EDT
A New York federal judge on Tuesday dismissed every claim but one in a bellwether case in multidistrict litigation alleging Merck & Co. Inc.'s osteoperosis drug Fosamax causes jaw deterioration, allowing...
To view the full article, register now.